Niantic, CT, United States of America

Jotham Wadsworth Coe

USPTO Granted Patents = 34 

 

 

Average Co-Inventor Count = 2.8

ph-index = 9

Forward Citations = 451(Granted Patents)


Location History:

  • Mystic, CT (US) (1995 - 1996)
  • East Lyme, CT (US) (1996)
  • Niantic, CT (US) (2000 - 2024)

Company Filing History:


Years Active: 1995-2024

Loading Chart...
Loading Chart...
Loading Chart...
34 patents (USPTO):Explore Patents

Title: Exploring the Innovations of Inventor Jotham Wadsworth Coe

Introduction:

Jotham Wadsworth Coe, a prolific inventor based in Niantic, CT (US), has made significant strides in the pharmaceutical industry with a total of 33 patents to his name.

Latest Patents:

1. Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors: Coe's groundbreaking invention revolves around novel imidazo[4,5-c]quinoline derivatives aimed at treating diseases associated with LRRK2, such as Parkinson's disease, Alzheimer's disease, cancer, Crohn's disease, and leprosy.

2. Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides: Coe's patent involves pharmaceutically active compounds that inhibit Janus Kinase (JAK), showcasing his expertise in developing treatments for various conditions mediated by JAK.

Career Highlights:

Coe has worked with reputable companies such as Pfizer Corporation, where his innovative spirit and dedication to pharmaceutical advancements have been instrumental in shaping the industry's landscape.

Collaborations:

Throughout his career, Coe has collaborated with esteemed professionals like Paige Roanne Palmer Brooks and Takushi Kaneko, demonstrating his ability to work synergistically with experts in the field to drive innovation forward.

Conclusion:

In conclusion, Jotham Wadsworth Coe's remarkable contributions to the pharmaceutical sector through his plethora of patents underscore his unwavering commitment to improving global healthcare. His innovative solutions hold great promise for the treatment and prevention of various debilitating diseases, solidifying his legacy as a pioneering inventor in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…